Tianjin Medical University (TMU), established in 1951, is a prestigious institution located in Tianjin, China. It was the first medical institution approved by the State Council after the founding of the People's Republic of China. The university was formed by merging Tianjin Medical College and Tianjin Second Medical College in 1993 and is now one of China's "211 Project" key universities. TMU offers a comprehensive range of programs with a strong emphasis on medical and life sciences. The university comprises 17 schools, including the School of Basic Medicine, School of Public Health, and School of Pharmacy, among others. It also hosts various specialized branches and an independent medical school. The faculty at TMU includes many distinguished professors and scholars, contributing to the university's status as a leading research and educational institution. The university is actively involved in international collaborations, including partnerships with over 50 universities globally and research collaborations with institutions like the University of Texas M. D. Anderson Cancer Center and Karolinska University Hospital.